Connection

Ryan Tedford to Phosphodiesterase 5 Inhibitors

Back to Details
This is a "connection" page, showing publications Ryan Tedford has written about Phosphodiesterase 5 Inhibitors.
Ryan Tedford
Connection Strength
0.375
Phosphodiesterase 5 Inhibitors
  1. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008 Nov; 1(4):213-9.
    View in: PubMed
    Score: 0.301
  2. Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis. J Card Fail. 2021 04; 27(4):477-485.
    View in: PubMed
    Score: 0.044
  3. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2015 Nov 01; 192(9):1102-10.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.